In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bill Blass dies at 79

This article was originally published in The Rose Sheet

Executive Summary

Fashion designer passes away June 12 from cancer, according to fashion house. Blass, who began designing clothes under his own name in 1960 when he worked for the Maurice Rentner fashion house, also lent his name to fragrances, currently marketed under a licensing agreement by Five Star Fragrances. Bill Blass was introduced in 1978, but the brand was not extended with another fragrance until 1999, when Amazing Bill Blass debuted, followed by a men's version in 2000 (1"The Rose Sheet" March 8, 1999, p. 12 and 2"The Rose Sheet" Feb. 21, 2000, p. 5). Blass created the Bill Blass fashion house in 1970, but sold the business in 1999...

You may also be interested in...



Bill Blass Creates "Amazing" Fragrance Duo With Men's Launch

Bill Blass Amazing for Men, brother fragrance to the designer's women's offering, is slated to debut in the fall. A "genuine and unsullied" scent, Amazing for Men is a mix of "the smart and the sensual," Bill Blass mark licensee Five Star Fragrances said.

Bill Blass Amazing Scent Reflects Designer's "Modern Femininity"

Packaging for Bill Blass Amazing visually emulates the designer's classic, elegant fashion style and his use of stark linear lines in his apparel creations, Riviera Concepts of America President Byron Donics said. Blass' newest women's fragrance introduction - set for a Mother's Day debut - is housed in a sleek, cylindrical frosted glass bottle laced with black lines, reminiscent of bamboo.

US FDA's Pediatric Experts, Not Review Division, Should Have Final Say On Pediatric Trials, Former Official Says

Former Associate Commissioner Janice Soreth says views of pediatric experts should take precedence over those of division directors regarding pediatric trials.

UsernamePublicRestriction

Register

RS010367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel